An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
TELA Bio, Inc. will announce its first quarter 2024 financial results on May 9, 2024. The company, focused on soft-tissue reconstruction solutions, will host a conference call and webcast to discuss the results and provide a corporate update.
TELA Bio, Inc. annuncerà i risultati finanziari del primo trimestre del 2024 il 9 maggio 2024. L'azienda, specializzata in soluzioni per la ricostruzione di tessuti molli, organizzerà una conferenza telefonica e un webcast per discutere i risultati e fornire un aggiornamento aziendale.
TELA Bio, Inc. anunciará los resultados financieros del primer trimestre de 2024 el 9 de mayo de 2024. La compañía, enfocada en soluciones para la reconstrucción de tejidos blandos, organizará una llamada de conferencia y una transmisión web para discutir los resultados y proporcionar una actualización corporativa.
TELA Bio, Inc.는 2024년 1분기 재무 결과를 2024년 5월 9일에 발표할 예정입니다. 부드러운 조직 재건 해결책에 중점을 둔 이 회사는 결과를 논의하고 기업 업데이트를 제공하기 위해 컨퍼런스 콜과 웹캐스트를 주최할 것입니다.
TELA Bio, Inc. annoncera ses résultats financiers du premier trimestre 2024 le 9 mai 2024. L'entreprise, spécialisée dans les solutions de reconstruction de tissus mous, organisera une conférence téléphonique et un webcast pour discuter des résultats et fournir une mise à jour de l'entreprise.
TELA Bio, Inc. wird seine Finanzergebnisse für das erste Quartal 2024 am 9. Mai 2024 bekannt geben. Das auf Weichteil-Rekonstruktionslösungen spezialisierte Unternehmen wird eine Telefonkonferenz und ein Webcast veranstalten, um die Ergebnisse zu diskutieren und ein Unternehmensupdate zu geben.
Positive
None.
Negative
None.
MALVERN, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report first quarter 2024 financial results on Thursday, May 9, 2024. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
First Quarter Earnings Conference Call and Webcast Details Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.
About TELA Bio, Inc. TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Caution Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.
When will TELA Bio announce its first quarter 2024 financial results?
TELA Bio will announce its first quarter 2024 financial results on Thursday, May 9, 2024.
What is TELA Bio's main focus as a company?
TELA Bio is a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions.
How can investors listen to the conference call discussing the financial results?
Investors interested in listening to the conference call should register online in advance. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.
tela bio, inc., a surgical reconstruction company, was created out of the desire to do things differently. combining the drive and innovation of a start-up with a seasoned medical technology team, the company aims to commercialize a portfolio of products that are purposefully designed to address a range of unmet needs in soft tissue repair. based in malvern, pennsylvania, this science-driven company is collaborating with leading surgeons to reinvigorate the soft tissue reconstruction market and bring cost-effective solutions to hospitals, surgeons and patients. please see our social media community guidelines at http://bit.ly/1uvcx0l